Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Immuron (IMRN) Shares Outstanding (Weighted Average) (2016 - 2025)

Immuron has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $147.9 million for Q2 2025.

  • For Q2 2025, Shares Outstanding (Weighted Average) fell 1.51% year-over-year to $147.9 million; the TTM value through Jun 2025 reached $147.9 million, down 1.51%, while the annual FY2025 figure was $149.7 million, 0.16% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2025 was $147.9 million at Immuron, up from $57.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $885.0 million in Q3 2024 and troughed at $57.9 million in Q4 2024.
  • A 5-year average of $374.1 million and a median of $150.2 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 1337.97% in 2023 and later plummeted 89.94% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $64.4 million in 2021, then dropped by 9.74% to $58.1 million in 2022, then skyrocketed by 890.82% to $575.7 million in 2023, then plummeted by 89.94% to $57.9 million in 2024, then soared by 155.3% to $147.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IMRN at $147.9 million in Q2 2025, $57.9 million in Q4 2024, and $885.0 million in Q3 2024.